Bacterial Nosocomial Infections: Multidrug Resistance as a Trigger for the Development of Novel Antimicrobials

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Nosocomial bacterial infections cause significant morbidity and mortality worldwide.
• The COVID-19 pandemic exacerbated the rise of multidrug-resistant (MDR) bacteria in hospitals.
• Existing antibiotics show limited efficacy against emerging MDR nosocomial infections.

Purpose of the Study:

• To review novel therapeutic strategies for treating nosocomial bacterial infections.
• To analyze emerging antibacterial alternatives, including metal-based complexes, antimicrobial peptides, and antisense therapeutics.
• To discuss the combination of new agents with existing antibiotics and drug repurposing.

Main Methods:

• Literature review of current research on antibacterial alternatives.
• Focus on metal-based complexes, antimicrobial peptides, and antisense antimicrobial therapeutics.
• Analysis of combination therapies and drug repurposing strategies.

Main Results:

• Several novel antibacterial approaches are under investigation.
• Metal-based complexes, antimicrobial peptides, and antisense agents show promise.
• Combination therapies and repurposed drugs offer potential solutions.

Conclusions:

• Novel therapeutic strategies are crucial to address the challenge of MDR nosocomial infections.
• Metal-based complexes, antimicrobial peptides, and antisense therapeutics represent promising avenues.
• Combining new agents with existing drugs and repurposing are viable strategies to enhance treatment efficacy.